MEDIORG2026-08-31MEDIORG2026-08-312026-08-31RelatedPartyTransactionDomain1MEDIORG2026-08-312026-08-31RelatedPartyTransactionDomain2MEDIORG2026-08-312026-08-31RelatedPartyTransactionDomain3MEDIORG2026-08-312026-08-31ResolutionOrAgendaDomain1MEDIORG2026-08-31ResolutionOrAgendaDomain1MEDIORG2026-08-312026-08-31ResolutionOrAgendaDomain2MEDIORG2026-08-31ResolutionOrAgendaDomain2MEDIORG2026-08-312026-08-31ResolutionOrAgendaDomain3MEDIORG2026-08-31ResolutionOrAgendaDomain3MEDIORG2026-08-312026-08-31ResolutionOrAgendaDomain4MEDIORG2026-08-31ResolutionOrAgendaDomain4iso4217:INRxbrli:pureMEDIORGMedicamen Organics LimitedNew2026-08-3118:07:002026-08-31Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)1Friday2025-09-2511:00:0010, Community Centre No. 2, Ashok Vihar Phase II, New Delhi, Delhi – 1100524Medicamen Organics LimitedGrande Etoile Pharmaceuticals LimitedSubsidiary and Related Party of Medicamen Organics Limited.Loan400000002026-04-012027-03-31Approval is sought for transactions to be entered into during FY 2026-27.Medicamen Organics LimitedGrande Etoile Pharmaceuticals LimitedSubsidiary and Related Party of Medicamen Organics Limited.Any other transactionReimbursement of expenses50000002026-04-012027-03-31Approval is sought for transactions to be entered into during FY 2026-27.Medicamen Organics LimitedGrande Etoile Pharmaceuticals LimitedSubsidiary and Related Party of Medicamen Organics Limited.Sale of goods or services500000002026-04-012027-03-31Approval is sought for transactions to be entered into during FY 2026-27.Ordinary ResolutionAdoption of Financial StatementsTo consider and adopt the Audited (Standalone and Consolidated) Financial Statements of the Company for the financial year ended on March 31, 2026, comprising of the Balance Sheet as at March 31, 2026, Statement of Profit & Loss for the year ended on that date, Cash Flow Statement and Statement of changes in Equity as at March 31, 2026 along with the explanatory notes annexed thereto and forming part of the aforesaid documents and the reports of the Board of Directors and the Auditors thereon.Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationTo re-appoint Mr. Ashutosh Gupta (DIN: 00039995), who retires by rotation, and, being eligible, offers himself for re-appointment as Director.Executive DirectorAshutosh Gupta000399952026-09-252029-09-24Ordinary ResolutionOthersOthersRe-appointment of Secretarial AuditorTo approve the re-appointment of Ms. Divya Rani, Proprietor of M/s. Divya Rani & Associates, Practising Company Secretaries, Membership No. A64841, Certificate of Practice No. 26426, as the Secretarial Auditors of the Company for the financial year 2026-27Ordinary ResolutionRelated Party TransactionTo approve material related party transactions with Grande Etoile Pharmaceuticals Limited, Subsidiary and Related Party of the Company.